1. Home
  2. SLGL vs OPTX Comparison

SLGL vs OPTX Comparison

Compare SLGL & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • OPTX
  • Stock Information
  • Founded
  • SLGL 1997
  • OPTX 1981
  • Country
  • SLGL Israel
  • OPTX United States
  • Employees
  • SLGL N/A
  • OPTX N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • OPTX Blank Checks
  • Sector
  • SLGL Health Care
  • OPTX Finance
  • Exchange
  • SLGL Nasdaq
  • OPTX Nasdaq
  • Market Cap
  • SLGL 69.1M
  • OPTX 60.9M
  • IPO Year
  • SLGL 2018
  • OPTX N/A
  • Fundamental
  • Price
  • SLGL $39.30
  • OPTX $2.07
  • Analyst Decision
  • SLGL
  • OPTX
  • Analyst Count
  • SLGL 0
  • OPTX 0
  • Target Price
  • SLGL N/A
  • OPTX N/A
  • AVG Volume (30 Days)
  • SLGL 19.1K
  • OPTX 200.8K
  • Earning Date
  • SLGL 11-14-2025
  • OPTX 11-13-2025
  • Dividend Yield
  • SLGL N/A
  • OPTX N/A
  • EPS Growth
  • SLGL N/A
  • OPTX N/A
  • EPS
  • SLGL N/A
  • OPTX N/A
  • Revenue
  • SLGL $23,931,000.00
  • OPTX $28,816,530.00
  • Revenue This Year
  • SLGL N/A
  • OPTX N/A
  • Revenue Next Year
  • SLGL $31.17
  • OPTX N/A
  • P/E Ratio
  • SLGL N/A
  • OPTX N/A
  • Revenue Growth
  • SLGL 264.86
  • OPTX 2.45
  • 52 Week Low
  • SLGL $4.01
  • OPTX $0.85
  • 52 Week High
  • SLGL $52.26
  • OPTX $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 67.60
  • OPTX 63.69
  • Support Level
  • SLGL $34.80
  • OPTX $1.50
  • Resistance Level
  • SLGL $52.26
  • OPTX $1.93
  • Average True Range (ATR)
  • SLGL 4.38
  • OPTX 0.15
  • MACD
  • SLGL 0.93
  • OPTX 0.04
  • Stochastic Oscillator
  • SLGL 47.70
  • OPTX 99.72

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Share on Social Networks: